Latest News about NVCR
Recent news which mentions NVCR
Benzinga's Top Ratings Upgrades, Downgrades For January 20, 2022
January 20, 2022
From Benzinga
From Benzinga
3 Top Healthcare Stocks to Buy for January
January 08, 2022
From Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
January 06, 2022
From Benzinga
7 Pharmaceutical Stocks That Could Make You Rich
January 06, 2022
From InvestorPlace
Stocks That Hit 52-Week Lows On Wednesday
January 05, 2022
From Benzinga
Stocks Hitting New 52-Week Lows Today
January 03, 2022
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 3, 2022
January 03, 2022
From Benzinga
3 Biotech Stocks That Are Too Cheap to Ignore
December 19, 2021
From Motley Fool
Is It Time to Buy the 3 Worst-Performing Growth Stocks of 2021?
December 03, 2021
From Motley Fool
These 60 stocks, including DraftKings, Zillow and Virgin Galactic, are down at least 50% from their 2021 highs
November 29, 2021
From MarketWatch
Novocure Posts Data For Tumor Treating Fields In Brain Tumor Trial
November 15, 2021
Tickers
NVCR
From Benzinga
3 Healthcare Stocks That Could Be Turkeys in November
October 29, 2021
From Motley Fool
From Benzinga
Earnings Scheduled For October 28, 2021
October 28, 2021
From Benzinga
The Week Ahead In Biotech (Oct. 24-30): Eyenovia, ANI Pharma, Clearside Medical FDA Decisions, Merck, Bristol-Myers Squibb Earnings, IPOs And More
October 24, 2021
From Benzinga
3 Stocks to Consider if the October Stock Market Sell-Off Worsens
October 17, 2021
From Motley Fool
This Unstoppable Cancer-Treatment Company's Stock Is on Sale Now
October 14, 2021
Tickers
NVCR
From Motley Fool
This Company's Device is Becoming Essential to Cancer Treatment -- Why Is the Stock Slumping?
October 12, 2021
Tickers
NVCR
From Motley Fool
Cramer Likes Ford, But Suggests Waiting For Dips To Buy These Stocks
October 11, 2021
From Benzinga
From Motley Fool
The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal
October 06, 2021
From Benzinga
Novocure To Test Its Tumor Treating Fields With Roche's Tecentriq In Pancreatic Cancer
September 14, 2021
From Benzinga
The Daily Biotech Pulse: NRx Rises On COVID-19 Drug Collaboration, Amgen's Lung Cancer Drug Conditionally Approved In Canada, Coherus Data Readout
September 14, 2021
From Benzinga
This Promising Healthcare Stock Is Down 50% From Its Highs; Should You Buy the Dip?
September 09, 2021
Tickers
NVCR
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.